These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 26933035)
1. Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes. Greifenhagen U; Frolov A; Blüher M; Hoffmann R J Biol Chem; 2016 Apr; 291(18):9610-6. PubMed ID: 26933035 [TBL] [Abstract][Full Text] [Related]
2. Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients. Greifenhagen U; Frolov A; Blüher M; Hoffmann R Anal Bioanal Chem; 2016 Aug; 408(20):5557-66. PubMed ID: 27236317 [TBL] [Abstract][Full Text] [Related]
3. Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment. Jaleel A; Halvatsiotis P; Williamson B; Juhasz P; Martin S; Nair KS Diabetes Care; 2005 Mar; 28(3):645-52. PubMed ID: 15735202 [TBL] [Abstract][Full Text] [Related]
4. Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus. Frolov A; Blüher M; Hoffmann R Anal Bioanal Chem; 2014 Sep; 406(24):5755-63. PubMed ID: 25074545 [TBL] [Abstract][Full Text] [Related]
5. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus. Kostolanská J; Jakus V; Barák L J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662 [TBL] [Abstract][Full Text] [Related]
6. Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes. Chiu CJ; Rabbani N; Rowan S; Chang ML; Sawyer S; Hu FB; Willett W; Thornalley PJ; Anwar A; Bar L; Kang JH; Taylor A Biofactors; 2018 May; 44(3):281-288. PubMed ID: 29718545 [TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes. Heidari F; Rabizadeh S; Rajab A; Heidari F; Mouodi M; Mirmiranpour H; Esteghamati A; Nakhjavani M Life Sci; 2020 Nov; 260():118422. PubMed ID: 32946914 [TBL] [Abstract][Full Text] [Related]
8. Global proteomic analysis of advanced glycation end products in the Bilova T; Paudel G; Shilyaev N; Schmidt R; Brauch D; Tarakhovskaya E; Milrud S; Smolikova G; Tissier A; Vogt T; Sinz A; Brandt W; Birkemeyer C; Wessjohann LA; Frolov A J Biol Chem; 2017 Sep; 292(38):15758-15776. PubMed ID: 28611063 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684 [TBL] [Abstract][Full Text] [Related]
10. Identification and relative quantification of specific glycation sites in human serum albumin. Frolov A; Hoffmann R Anal Bioanal Chem; 2010 Jul; 397(6):2349-56. PubMed ID: 20496030 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Quantification of Carboxymethyllysine-Modified Peptides in Human Plasma. Korwar AM; Zhang Q J Am Soc Mass Spectrom; 2021 Mar; 32(3):744-752. PubMed ID: 33512994 [TBL] [Abstract][Full Text] [Related]
12. Association of plasma proteins at multiple stages of glycation and antioxidant status with erythrocyte oxidative stress in patients with type 2 diabetes. Tupe RS; Diwan AG; Mittal VD; Narayanam PS; Mahajan KB Br J Biomed Sci; 2014; 71(3):93-9; quiz 138. PubMed ID: 25265752 [TBL] [Abstract][Full Text] [Related]
13. Long Term Dietary Restriction of Advanced Glycation End-Products (AGEs) in Older Adults with Type 2 Diabetes Is Feasible and Efficacious-Results from a Pilot RCT. Lotan R; Ganmore I; Shelly S; Zacharia M; Uribarri J; Beisswenger P; Cai W; Troen AM; Schnaider Beeri M Nutrients; 2020 Oct; 12(10):. PubMed ID: 33076217 [TBL] [Abstract][Full Text] [Related]
14. Poorly controlled type 2 diabetes with no progression of diabetes-related complications and low levels of advanced glycation end products: A Case report. Nakamura T; Tsujimoto T; Yasuda K; Chujo D; Ohsugi M; Tanabe A; Ueki K; Kajio H Medicine (Baltimore); 2019 Jul; 98(30):e16573. PubMed ID: 31348288 [TBL] [Abstract][Full Text] [Related]
15. Profile of urinary amino acids and their post-translational modifications (PTM) including advanced glycation end-products (AGEs) of lysine, arginine and cysteine in lean and obese ZSF1 rats. Baskal S; Büttner P; Werner S; Besler C; Lurz P; Thiele H; Tsikas D Amino Acids; 2022 Apr; 54(4):643-652. PubMed ID: 34250558 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. Zhang Q; Monroe ME; Schepmoes AA; Clauss TR; Gritsenko MA; Meng D; Petyuk VA; Smith RD; Metz TO J Proteome Res; 2011 Jul; 10(7):3076-88. PubMed ID: 21612289 [TBL] [Abstract][Full Text] [Related]
17. Effect of Advanced Glycation End Products on Cognition in Older Adults with Type 2 Diabetes: Results from a Pilot Clinical Trial. Lotan R; Ganmore I; Livny A; Itzhaki N; Waserman M; Shelly S; Zacharia M; Moshier E; Uribarri J; Beisswenger P; Cai W; Troen AM; Beeri MS J Alzheimers Dis; 2021; 82(4):1785-1795. PubMed ID: 34250935 [TBL] [Abstract][Full Text] [Related]
18. Sensitive and site-specific identification of carboxymethylated and carboxyethylated peptides in tryptic digests of proteins and human plasma. Greifenhagen U; Nguyen VD; Moschner J; Giannis A; Frolov A; Hoffmann R J Proteome Res; 2015 Feb; 14(2):768-77. PubMed ID: 25423611 [TBL] [Abstract][Full Text] [Related]
19. Products of Early and Advanced Glycation in the Soy Milk Proteome. Milkovska-Stamenova S; Krieg L; Hoffmann R Mol Nutr Food Res; 2019 Jan; 63(2):e1800725. PubMed ID: 30430721 [TBL] [Abstract][Full Text] [Related]
20. d-Ribose contributes to the glycation of serum protein. Chen Y; Yu L; Wang Y; Wei Y; Xu Y; He T; He R Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2285-2292. PubMed ID: 31085227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]